Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
Timing and Consequences on Behavior01:08

Timing and Consequences on Behavior

140
In operant conditioning, the timing of reinforcement is crucial. For animals like rats and cats, immediate reinforcement (within a few seconds) is much more effective than delayed reinforcement. For example, a food reward for a rat needs to follow within 30 seconds of pressing a bar to be effective. 
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
140
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Reason and Intuition01:37

Reason and Intuition

6.6K
The human brain processes information for decision-making using one of two routes: an intuitive system and a rational system (Epstein, 1994; popularized by Kahneman, 2011 as System 1 and System 2, respectively). The intuitive system is quick, impulsive, and operates with minimal effort, relying on emotions or habits to provide cues for what to do next, while the rational system is logical, analytical, deliberate, and methodical. Research in neuropsychology suggests that the...
6.6K
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

290
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
290
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

622
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
622

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From inhibition to excitation and why: The role of temporal urgency in modulating corticospinal activity.

Biological psychology·2026
Same author

The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis.

The lancet. Psychiatry·2025
Same author

Mark Hallett (1943-2025): A pioneer in brain stimulation.

Brain stimulation·2025
Same author

A computational approach to understanding effort-based decision-making in depression.

Psychological medicine·2025
Same author

Causes of Death in Anti-IgLON5 Disease: A Novel Case Report and Systematic Literature Review.

Brain sciences·2025
Same author

Defining the Rhythm: Developing a New Method to Describe Tremor and Myoclonus.

Movement disorders : official journal of the Movement Disorder Society·2025

Related Experiment Video

Updated: Aug 22, 2025

An Automated T-maze Based Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free Moving Rodents
07:42

An Automated T-maze Based Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free Moving Rodents

Published on: August 2, 2018

13.7K

Dopamine increases risky choice while D2 blockade shortens decision time.

Stephanie T Hirschbichler1,2,3, John C Rothwell4, Sanjay G Manohar4,5

  • 1Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK. stephanie.hirschbichler@gmail.com.

Experimental Brain Research
|November 9, 2022
PubMed
Summary

Dopamine precursor levodopa increased risky choices, while dopamine antagonist haloperidol sped up decisions in healthy volunteers. Individual dopamine levels and sensation-seeking traits influenced these drug effects on decision-making.

Keywords:
DopamineImpulsivityParkinson diseaseRisky decision-making

More Related Videos

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

9.5K
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

25.9K

Related Experiment Videos

Last Updated: Aug 22, 2025

An Automated T-maze Based Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free Moving Rodents
07:42

An Automated T-maze Based Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free Moving Rodents

Published on: August 2, 2018

13.7K
Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

9.5K
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

25.9K

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Pharmacology

Background:

  • Dopamine influences decision-making; its dysregulation can cause impulsive behavior.
  • Dopaminergic drug side effects, like impulsivity, are unpredictable in Parkinson's disease.
  • Individual dopamine levels and personality traits may modulate drug responses.

Purpose of the Study:

  • To investigate the effects of levodopa and haloperidol on risk-taking and decision-making speed.
  • To explore the role of baseline dopamine state and sensation-seeking in modulating these effects.

Main Methods:

  • Healthy volunteers completed a gambling task under placebo, levodopa, or haloperidol in a within-subject design.
  • Behavioral data on risky choices and deliberation times were collected.
  • Personality traits, including sensation-seeking, were assessed.

Main Results:

  • Levodopa increased the proportion of risky choices.
  • Haloperidol significantly reduced decision-making time.
  • Reduced deliberation on haloperidol was observed only in low sensation-seekers.
  • Levodopa did not affect deliberation time.

Conclusions:

  • Levodopa may increase risk-taking through D1/D2 receptor overstimulation.
  • Haloperidol might enhance decision speed via D2 blockade and subsequent D1 stimulation.
  • Individual differences in dopamine state and personality traits are critical for predicting dopaminergic drug effects.